PRVB - Provention Bio Inc. (PRVB) CEO Ashleigh Palmer on Q1 2022 Results - Earnings Call Transcript

Provention Bio, Inc. (PRVB) Q1 2022 Earnings Conference Call May 5, 2022, 8:00 AM ET Company Participants Ashleigh Palmer – Co-Founder, President, Chief Executive Officer Francisco Leon – Co-Founder & Chief Scientific Officer Thierry Chauche – Chief Financial Officer Jason Hoitt – Chief Commercial Officer Robert Doody – Vice President, Investor Relations Conference Call Participants Gregory Renza – RBC Capital Markets Thomas Smith – SVB Leerink David Hoang – SMBC Nikko Securities America, Inc Presentation Operator Good morning. My name is Kate, and I will be your conference Operator today. At this time, I would like to welcome everyone to the Provention Bio call. There will be a question-and-answer session to follow. Please be advised that this call is being recorded at the company's request. I would now like to turn the call over to Mr. Robert Doody, Vice President of Investor Relations for Provention Bio. Robert Doody Thank you,

For further details see:

Provention Bio, Inc. (PRVB) CEO Ashleigh Palmer on Q1 2022 Results - Earnings Call Transcript